Fifth Third Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Fifth Third Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.37M	Buy	8,709 +108	+1%	+$51.8K	0.12%	125
2026 Q1	$4.23M	Buy	8,601 +316	+4%	+$171K	0.14%	117
2025 Q4	$4.8M	Buy	8,285 +807	+11%	+$456K	0.17%	100
2025 Q3	$3.63M	Buy	7,478 +159	+2%	+$74K	0.13%	117
2025 Q2	$2.97M	Buy	7,319 +282	+4%	+$118K	0.12%	121
2025 Q1	$3.5M	Buy	7,037 +73	+1%	+$39.5K	0.18%	96
2024 Q4	$3.62M	Buy	6,964 +3,067	+79%	+$1.69M	0.2%	79
2024 Q3	$2.41M	Buy	3,897 +306	+9%	+$181K	0.15%	101
2024 Q2	$1.99M	Buy	3,591 +1,194	+50%	+$684K	0.15%	92
2024 Q1	$1.39M	Buy	2,397 +469	+24%	+$263K	0.22%	76
2023 Q4	$1.02M	Sell	1,928 -172	-8%	-$83.3K	0.33%	68
2023 Q3	$1.06M	Buy	2,100 +577	+38%	+$307K	0.43%	63
2023 Q2	$795K	Buy	1,523 +442	+41%	+$239K	0.51%	54
2023 Q1	$623K	Buy	+1,081	New	+$609K	1.15%	34

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Fifth Third Wealth Advisors's TMO Position: Q2 2026 in Review

Fifth Third Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.3% in Q2 2026, buying an estimated $51.8K and bringing the position to 8,709 shares worth $4.37M. The position accounts for 0.12% of the portfolio, ranked #125.

Fifth Third Wealth Advisors first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.8M in Q4 2025. 429 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Fifth Third Wealth Advisors held 8,709 shares of Thermo Fisher Scientific worth $4.37M as of Q2 2026.
Fifth Third Wealth Advisors bought 108 Thermo Fisher Scientific shares in Q2 2026, an estimated $51.8K.
Thermo Fisher Scientific made up 0.12% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #125 holding.
Fifth Third Wealth Advisors first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
Fifth Third Wealth Advisors's Thermo Fisher Scientific position peaked at $4.8M in Q4 2025.
429 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.